Hanson Wade: FcRn-Targeted Therapies for Autoimmune Disorders Summit
Taking place as a fully interactive virtual meeting, the FcRn-Targeted Therapies for Autoimmune Disorders Summit is the only industry-led meeting bringing you the most up-to-date clinical and commercial developments utilizing FcRn antagonists in rare and autoimmune diseases.
The 3-day program will bring together a wealth of knowledge into the complexities of the FcRn-IgG interaction and the therapeutic strategies which are being employed to yield clinical efficacy. Expect to hear from industry leaders showcasing clinical candidates aimed at disrupting the autoantibody interaction and increasing the clearance of pathogenic IgG from the body.
Join dozens of industry experts online from the likes of CSL Behring, Eli Lilly, Roche, Momenta, Alexion, Argenx, and more to discuss FcRn MOA, preclinical model selection and translation, high throughput assays for ligand screening, IgG engineering, and DMPK modelling to ensure best in class medicines are brought to patients. Get involved in an exclusive workshop lead by the FDA who will be exploring protein immunogenicity to better understand FcRn drug development.
Download the full event guide for the full conference agenda and speaker line-up.
Contact: Adam Griffiths
Contact Phone: +1 617 455 4188
Contact Email: email@example.com